MoneyWorks4Me

Piramal Pharma informs about disclosures

31 May 2024 Evaluate
Piramal Pharma has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1845.40
Dr. Reddys Labs. 1219.20
Cipla 1386.20
Lupin 2058.40
Zydus Lifesciences 1209.10
View more..